Pulmonary Arterial Hypertension Flashcards

1
Q

PH

A

continuous high BP in pulmonary arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

meds that cause PH

A

codeine
SSRI during pregnancy inc risk of persistent PH of newborn (PPHN)
weight-loss: diethylpropion, phendimetrazine, phentermine)
methamphetamines/amphetamines
others: dasatinib, diazoxide, fenfluramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathophysiology of PH

A

imbalance of vasoconstrictor and vasodilator
vasoconstrictor: endothelin-1 and thromboxane A2 (TXA2)
vasodilator: prostacyclines
HF is most common cause of death in PAH
lung/heart-lung transplant may be option for younger patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

symptoms of PAH

A

fatigue, dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

non-drug treatment of PAH

A

sodium restrict to <2.4 g/day
avoid NSAIDs and other Na/H2O-retention meds
routine flu and pneumococcal shots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drug treatment of PAH

A

confirm diagnosis with right heart catheterization (vasoreactivity tested)

if responder (mPAP drops >=10 and to <40) - give CCB (long-acting nifedipine, diltiazem, and amlodipine); do not use verapamil bc negative inotrope

if non-responder: vasodilators (prostacyclin analogs and receptor agonists, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, soluble guanylate cyclase stimulator; IV epoprostenol dec mortality and first line

supportive therapies: loops for volume overload; digoxin for CO/control HR; drugs for pro-thrombotic state - warfarin with INR goal 1.5-2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

prostacyclin analogues (prostanoids) and receptor agonists

A

epoprostenol, treprostinil, remodulin, iloprost, selexipag
potent vasodilators and inhibitors of platelet aggregation
continuous IV at home

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

epoprostenol dosing

A

continuous IV
2 ng/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

treprostinil dosing

A

Remodulin: continuous SC or IV infusion ng/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

prostacyclin analogues warnings

A

vasodilation (hypotension, flushing)
rebound PH
chronic iv infusions: infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

prostacyclin analogues side effects

A

hypotension
flushing
jaw pain
infusion-site pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

prostacyclin anagloues notes

A

parenteral agents: potent vasodilators; avoid interruptions and sudden, large dose reductions

epoprostenol: must protect from light during infusion

Flolan: reconstituted solution require ice packs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

endothelin receptor antagonists

A

bosentan, ambrisentan, macitentan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

endothelin receptor antagonists BBW

A

teratogenic: must have negative pregnancy test before starting and monthly during

Bosentan: hepatotoxicity

REMS program only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

endothelin receptor antagonists CI

A

pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

endothelin receptor antagonists warnings

A

hepatotoxicity
dec Hbg/Hct
fluid retention

17
Q

endothelin receptor antagonists side effects

A

headache

18
Q

endothelin receptor antagonist DI

A

Bosentan: dec effectiveness of hormonal contraceptive

19
Q

PDE-5 inhibitors

A

inc cGMP = pulmonary vasculature relaxation and vasodilation
sildenafil, tadalafil

20
Q

PDE-5 inhibitors CI

A

nitrates

21
Q

PDE-5 inhibitors warnings

A

hearing loss
vision loss (NAION)
hypotension
priapism

22
Q

PDE-t inhibitors side effects

A

headache

23
Q

PDE-5 inhibitor DI

A

do not use with nitreates = low BP; absolute CI

caution with alpha-blocker (or other antihypertensives) = hypotension

24
Q

soluble guanylate cyclase stimulator

A

guanylate cyclase is receptor for endogenous NO
Riociguat sensitizes sGC and directly stimulates = inc cGMP = relaxation of pulmonary artery smooth muscle cells

25
Q

Riociguat BBW

A

teratogenic (negative pregnancy test before and monthly during)
only through REMS

26
Q

riociguat CI

A

pregnancy
use of PDE-5i or nitreates

27
Q

riociguat warnings

A

hypotension

28
Q

riociguat side effects

A

headache

29
Q

riociguat DI

A

do not use with nitrate = dec BP

30
Q

pulmonary fibrosis

A

scarred and damaged lung tissue
presentation of exertional dyspnea